HeartSciences Inc.

HeartSciences is a medical technology company that develops artificial intelligence-driven electrocardiography solutions to enhance cardiac care. Its flagship product is MyoVista Insights, a cloud-based, device-agnostic ECG data management platform designed to organize clinical workflows and integrate multi-vendor AI-ECG algorithms. The company also develops the MyoVista wavECG device, a point-of-care resting twelve-lead ECG system engineered to host embedded cardiac analysis algorithms. HeartSciences serves healthcare providers ranging from primary care settings to large hospital systems and cardiology practices seeking modernized ECG infrastructure and risk assessment tools.

The company operates primarily in the United States and maintains international intellectual property protections across jurisdictions including Europe, Canada, Japan, India, and China. HeartSciences employs a five-person research and development staff to advance its proprietary software and device capabilities. The company’s headquarters are not stated in the provided text.

Summary of the business section of HeartSciences's latest annual report, written by StockData.